Asia/Oceania
The Chinese firm saw increasing domestic competition while geopolitics impacted its multiomics and synthetic biology service business in the Americas.
Prostate Cancer Study Leads to Prediction Models Based on Proteins in Blood, Urine
Starting with spatial transcriptomic data and pseudotime models, researchers found prostate cancer markers backed up by available expression, proteomic, and other data.
Pacific Biosciences Licenses DNA Methylation Detection Tech from Chinese University of Hong Kong
Developed by the team of Dennis Lo, the deep learning-based models will enable the detection of 5hmC, hemimethylated 5mC, and 6mA in standard HiFi sequencing runs.
Craif Raises $22M in Series C Round to Expand US, Japan Operations
The Nagoya University spinout will open an office in San Diego and is working toward FDA approval of its miSignal early cancer detection test.
Guardant Health, Pfizer Partner to Use Liquid Biopsy to Aid Cancer Therapy Development
Pfizer intends to use Guardant's blood-based tests in global clinical trials, with specific plans to evaluate the clinical utility of its Reveal assay as clinical trial surrogate endpoint.